Podocalyxin expression in malignant astrocytic tumors

被引:35
|
作者
Hayatsu, Norihito [2 ]
Kaneko, Mika Kato [1 ]
Mishima, Kazuhiko [3 ]
Nishikawa, Ryo [3 ]
Matsutani, Masao [3 ]
Price, Janet E. [1 ]
Kato, Yukinari [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Cell Biol, Unit 173, Houston, TX 77030 USA
[2] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan
[3] Saitama Med Univ, Int Med Ctr, Hidaka, Saitama 3501298, Japan
关键词
podocalyxin; keratan sulfate; proteoglycan; astrocytic tumor; glioblastoma;
D O I
10.1016/j.bbrc.2008.07.049
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Podocalyxin is an anti-adhesive mucin-like transmembrane sialoglycoprotein that has been implicated in the development of aggressive forms of cancer. Podocalyxin is also known as keratan sulfate (KS) proteoglycan. Recently, we revealed that highly sulfated KS or another mucin-like transmembrane sialoglycoprotein podoplanin/aggrus is upregulated in malignant astrocytic tumors. The aim of this study is to examine the relationship between Podocalyxin expression and malignant progression of astrocytic tumors. in this study, 51 astrocytic tumors were investigated for Podocalyxin expression using immunohistochemistry, Western blot analysis, and quantitative real-time PCR. Immunohistochemistry detected Podocalyxin on the surface Of tumor cells in six of 14 anaplastic astrocytomas (42.9%) and in 17 of 31 glioblastomas (54.8%), especially around proliferating endothelial cells. In diffuse astrocytoma, Podocalyxin expression was observed only in vascular endothelial cells. Podocalyxin might be associated with the malignant progression Of astrocytic tumors, and be a useful prognostic market for astrocytic tumors. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:394 / 398
页数:5
相关论文
共 50 条
  • [31] Chromosome Instability in Malignant Astrocytic Tumors Detected by Fluorescence in situ Hybridization
    Takafumi Nishizaki
    Katsumi Harada
    Hisashi Kubota
    Kei Harada
    Tomoko Furuya
    Michiyasu Suzuki
    Kohsuke Sasaki
    Journal of Neuro-Oncology, 2002, 56 : 159 - 165
  • [32] ASTROCYTIC TUMORS
    MARGAIN, D
    PERETTIVITON, P
    ARNAUD, O
    MARTINI, P
    SALAMON, G
    JOURNAL OF NEURORADIOLOGY, 1991, 18 (02) : 141 - 152
  • [33] Correlation of eNOS and VEGF expression with malignancy in patients with astrocytic tumors
    Erdamar, S
    Oz, B
    Tannover, N
    MODERN PATHOLOGY, 2001, 14 (01) : 207A - 207A
  • [34] EXPRESSION OF THE P53 PROTEIN IN A SPECTRUM OF ASTROCYTIC TUMORS
    ELLISON, DW
    GATTER, KC
    STEART, PV
    LANE, DP
    WELLER, RO
    JOURNAL OF PATHOLOGY, 1992, 168 (04): : 383 - 386
  • [35] Expression of apoptosis and its related protein in astrocytic tumors.
    Takekawa Y.
    Sawada T.
    Sakurai I.
    Brain Tumor Pathology, 1999, 16 (1) : 11 - 16
  • [36] Correlation of eNOS and VEGF expression with malignancy in patients with astrocytic tumors
    Erdamar, S
    Oz, B
    Tannover, N
    LABORATORY INVESTIGATION, 2001, 81 (01) : 207A - 207A
  • [37] CEREBRAL MICROENVIRONMENT INFLUENCES EXPRESSION OF THE VITRONECTIN GENE IN ASTROCYTIC TUMORS
    GLADSON, CL
    WILCOX, JN
    SANDERS, L
    GILLESPIE, GY
    CHERESH, DA
    JOURNAL OF CELL SCIENCE, 1995, 108 : 947 - 956
  • [38] Expression and release of CD14 in astrocytic brain tumors
    Martin H. Deininger
    Richard Meyermann
    Hermann J. Schluesener
    Acta Neuropathologica, 2003, 106 : 271 - 277
  • [39] Expression of the angiogenic factor thymidine phosphorylase in human astrocytic tumors
    S. Takano
    K. Tsuboi
    A. Matsumura
    Y. Tomono
    Y. Mitsui
    T. Nose
    Journal of Cancer Research and Clinical Oncology, 2000, 126 : 145 - 152
  • [40] Pathologic significance of proliferative activity and oncoprotein expression in astrocytic tumors
    Bian, XW
    Shi, JQ
    Liu, FX
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2000, 22 (06): : 429 - 437